American Trust’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,274
Closed -$91.7K 320
2023
Q3
$91.7K Sell
11,274
-859
-7% -$7.02K 0.01% 281
2023
Q2
$91.8K Sell
12,133
-529
-4% -$4.04K 0.01% 415
2023
Q1
$101K Sell
12,662
-262
-2% -$2.69K 0.01% 429
2022
Q4
$147K Sell
12,924
-320
-2% -$3.49K 0.01% 421
2022
Q3
$116K Buy
13,244
+2,052
+18% +$21.3K 0.01% 407
2022
Q2
$111K Sell
11,192
-438
-4% -$4.41K 0.01% 433
2022
Q1
$117K Buy
11,630
+1,032
+10% +$11K 0.01% 493
2021
Q4
$134K Buy
+10,598
New +$138K 0.01% 361

Other funds holding PTVE

American Trust's PTVE Position: Q4 2023 in Review

American Trust sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q4 2023, closing a stake of 11,274 shares — an estimated $91.7K sold.

American Trust first reported a position in PTVE in Q4 2021 and held it in 8 quarters. The position peaked at $147K in Q4 2022. 127 funds tracked by Wall St. Rank hold PTVE as of Q4 2023.

  • American Trust reported no remaining Pactiv Evergreen Inc. Common stock position as of Q4 2023 after selling out during the quarter.
  • American Trust sold 11,274 Pactiv Evergreen Inc. Common stock shares in Q4 2023, an estimated $91.7K.
  • American Trust first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2021 and held it in 8 quarters.
  • American Trust's Pactiv Evergreen Inc. Common stock position peaked at $147K in Q4 2022.
  • 127 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q4 2023.

Based on American Trust's 13F filing for Q4 2023, filed 21 Feb 2024.